Literature DB >> 11100751

Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hormone.

R Watabe1, K Shibata, N Hirase, T Kodera, K Muta, J Nishimura, H Nawata.   

Abstract

A case of angiotropic B-cell lymphoma associated with hemophagocytic syndrome (HPS) has been reported. In addition to fever, pancytopenia, hepatosplenomegaly, and lack of lymphadenopathy, unique clinical features, such as syndrome of inappropriate secretion of antidiuretic hormone (SIADH) and pulmonary infarction, were manifested. Both soluble interleukin-2 receptor (sIL-2R) and IL-6 were elevated in the patient's sera in addition to an increase of serum lactate dehydrogenase and ferritin. In contrast, tumor necrosis factor-alpha and interferon-gamma were within normal ranges. Serum antibodies against Epstein-Barr virus and cytomegalovirus showed a past infection pattern. An autopsy examination revealed systemic intravascular proliferation of lymphoma cells with a B-cell phenotype, confirming the diagnosis of angiotropic B-cell lymphoma. Moreover, SIADH was suggested to result from the infiltration of tumor cells into the pituitary gland. Triple association of angiotropic B-cell lymphoma, HPS and SIADH is quite rare. Therefore, the present case seems to be helpful for clarifying the mechanism for HPS of non-Hodgkin's lymphoma with B-cell origin.

Entities:  

Mesh:

Year:  2000        PMID: 11100751     DOI: 10.1007/s002770000188

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.

Authors:  Yasufumi Masaki; Lingli Dong; Akio Nakajima; Haruka Iwao; Miyuki Miki; Nozomu Kurose; Eriko Kinoshita; Takayuki Nojima; Toshioki Sawaki; Takafumi Kawanami; Masao Tanaka; Kumiko Shimoyama; Changi Kim; Masaaki Fukutoku; Hiroshi Kawabata; Toshihiro Fukushima; Yuko Hirose; Tomoo Takiguchi; Susumu Konda; Susumu Sugai; Hisanori Umehara
Journal:  Int J Hematol       Date:  2009-04-14       Impact factor: 2.490

2.  Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient.

Authors:  Kar-Ming Fung; Jennifer H Chakrabarty; William F Kern; Hany Magharyous; Bradley C Gehrs; Shibo Li
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

Review 3.  A new approach to the diagnosis and treatment of intravascular lymphoma.

Authors:  Joachim M Baehring; Janina Longtine; Fred H Hochberg
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

4.  Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression.

Authors:  Emiko Takahashi; Kazuyoshi Kajimoto; Toshiaki Fukatsu; Megumi Yoshida; Tadaaki Eimoto; Shigeo Nakamura
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

5.  A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.

Authors:  Tomas Büchler; Christelle Ferra; Nuria Virgili; Eduard Montanya; Albert Grañena
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

6.  Syndrome of inappropriate antidiuretic hormone secretion associated with acute myeloid leukemia with multilineage dysplasia.

Authors:  Shoko Nakayama; Taiji Yokote; Kichinosuke Kobayashi; Yuji Hirata; Toshikazu Akioka; Takuji Miyoshi; Takayuki Takubo; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

7.  Natural killer/T-cell lymphoma with concomitant syndrome of inappropriate antidiuretic hormone secretion: A case report and review of literature.

Authors:  Quan-Bo Liu; Rui Zheng
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

8.  Malignant lymphoma in the parasellar region.

Authors:  Takao Koiso; Hiroyoshi Akutsu; Shingo Takano; Tetsuya Yamamoto; Eiichi Ishikawa; Yasushi Okoshi; Akira Matsumura
Journal:  Case Rep Med       Date:  2014-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.